IncobotulinumtoxinA Versus OnabotulinumtoxinA for Treatment of Overactive Bladder Syndrome: A Randomized Single-blinded Non-inferiority Trial

Posted by author-avatar

Publication date: Available online 31 March 2026

Source: Urology

Author(s): Anna S. Trikhacheva, Sara J. Hamade, Jordan D. Gisseman, Cara Olsen, Christine M. Vaccaro, Katherine L. Dengler

Read More

Newer
Reply to Editorial Comment on “From Lichtleiter to Laser: A 200-Year Odyssey of Transurethral Resection of Bladder Tumors”
Older Corrigendum to ‘First Use of the FloStent for Catheter-Dependent Urinary Retention Secondary to Benign Prostatic Hyperplasia: Additional Results From the RAPID I Study’ [Urology 208 (2025) 17-20]